21701440

Source:http://linkedlifedata.com/resource/pubmed/id/21701440

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0011860, umls-concept:C2746078, umls-concept:C2917389
pubmed:issue	1367
pubmed:dateCreated	2011-6-24
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985240R
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Dipeptidyl-Peptidase IV Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Linaclotide Acetate, http://linkedlifedata.com/resource/pubmed/chemical/Purines, http://linkedlifedata.com/resource/pubmed/chemical/Quinazolines
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1523-2859
pubmed:issnType	Electronic
pubmed:day	27
pubmed:volume	53
pubmed:owner	NLM
pubmed:pagination	49-50
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:21701440-Animals, pubmed-meshheading:21701440-Clinical Trials as Topic, pubmed-meshheading:21701440-Diabetes Mellitus, Type 2, pubmed-meshheading:21701440-Dipeptidyl-Peptidase IV Inhibitors, pubmed-meshheading:21701440-Drug Therapy, Combination, pubmed-meshheading:21701440-Humans, pubmed-meshheading:21701440-Hypoglycemic Agents, pubmed-meshheading:21701440-Purines, pubmed-meshheading:21701440-Quinazolines
pubmed:year	2011
pubmed:articleTitle	Linagliptin (Tradjenta)--a new DPP-4 inhibitor for type 2 diabetes.
pubmed:publicationType	Journal Article, Review